CB

Cellectar Biosciences

CLRB
NASDAQHealth Care

Income Statement

Total Revenue$0
Gross Profit$0
Operating Income$-51.78M
EBITDA$-44.22M
EBIT$-44.52M
Pre-tax Income$-20.84M
Net Income$-44.58M

Balance Sheet

Cash Equivalent$30.86M
Total Debt$521.49K
Book Value$14.97M
Book Value Per Share12.37

Key Ratios

Return on Equity (ROE)-284.38%
Return on Assets (ROA)-175.01%
Return on Invested Capital (ROI)-284.38%
Net Profit Margin-22270.00%
Current Ratio2.58
Quick Ratio2.48
Long-Term Debt / Equity0.00